Elan, Shire Pharmaceutical Group plc regulatory update

The FDA granted marketing approval to ELN's Carbatrol (carbamazepine)

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE